2024澳门2024免费原料-免费完整资料

Xu-Tao Chen, Jiang Qiu, Zi-Xuan Wu, Hui Zhang, Tong Chen, Shi-Cong Yang, Guo-Dong Zhao, Yu He, Xue Shen, Jin-Quan Luo, Yang Huang, Chang-Xi Wang, Li-Zhong Chen, Cheng-Lin Wu, Gang Huang.

Clinical Chemistry, hvac053, https://doi.org/10.1093/clinchem/hvac053

6) Analysis of cell-free fetal DNA in 16,843 pregnant women from a single center in China using targeted sequencing approach

Yang Zhou , Yinfeng Wang , Frank Peprah Addai , Xiaofeng Li , Xiuwen Zhang , Haitao Liu , Gongda Yang , Fengbo Zeng , Tingya Jiang , Junling Liu.

https://doi.org/10.1016/j.placenta.2022.03.126

7) Plasma donor-derived cell-free DNA levels are associated with the inflammatory burden and macrophage extracellular trap activity in renal allografts.

Luying Guo , Jia Shen , Wenhua Lei , Pengpeng Yan , Meifang Wang , Qin Zhou , Huiping Wang , Jianyong Wu , Jianghua Chen.

https://www.frontiersin.org/articles/10.3389/fimmu.2022.796326/abstract

8) Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study

Nie W, Su X, Liu L, Li J, Fu Q, Li X, Wu C, Wang J, Deng R, Chen E, Yang S, Li S, Zhang H, Wang C. Front Med (Lausanne). 2022 Jan 7;8:814517.

9) Donor-derived cell-free DNA: An independent biomarker in kidney transplant patients with antibody-mediated rejection

Cheng D, Liu F, Xie K, Zeng C, Li X, Ni X, Ge J, Shu L, Zhou Y, Shi H, Liu H, Chen J.Transpl Immunol. 2021 Dec;69:101404.

10) Urinary donor-derived cell-free DNA as a non-invasive biomarker for BK polyomavirus nephropathy

Shen J, Guo L, Lei W, Liu S, Yan P, Liu H, Zhou J, Zhou Q, Liu F, Jiang T, Wang H, Wu J, Chen J, Wang R. J Zhejiang Univ Sci B. 2021 Nov 15;22(11):917-928. English.

11) A novel urine cell-free DNA preservation solution and its application in kidney transplantation

Zhou Q, Liu F, Guo L, Chen R, Yuan X, Li C, Shu L, Liu H, Zhou Y, Wu Y, Shi H, Zhao H, Jiang T. Nephrology (Carlton). 2021 Aug;26(8):684-691.

12) The role of donor-derived cell-free DNA in the detection of renal allograft injury

Zhou Y, Cheng D, Jiang T. Nephrol Ther. 2021 Feb;17(1):12-17.

13) Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients

Zhao D, Zhou T, Luo Y, Wu C, Xu D, Zhong C, Cong W, Liu Q, Zhang J, Xia Q. Sci Rep. 2021 Jan 13;11(1):1138.

14) Prognostic value of the donor‐derived cell‐free DNA assay in acute renal rejection therapy: A prospective cohort study

Shen J, Guo L, Yan P, Zhou J, Zhou Q, Lei W, Liu H, Liu G, Lv J, Liu F, Huang H, Dong W, Shu L, Wang H, Wu J, Chen J, Wang R. Clin Transplant. 2020 Oct;34(10):e14053.

15) Urine Donor–Derived Cell-Free DNA Helps Discriminate BKPyAN in Kidney Transplant Recipients With BK Polyomavirus Infection

Chen XT, Chen WF, Li J, Deng RH, Huang Y, Yang SC, Chen PS, Jiang TY, Liu HT, Wang CX, Chen LZ, Qiu J, Huang G.Front Immunol. 2020 Aug 19;11:1763.

16) 嵌合抗原受体调节性T细胞免疫疗法在器官移植中的应用

吴俣李佩璐葛军蒋廷亚, 《器官移植》2020,11(5):547-552

17) Donor-Derived Cell-Free DNA in Urine Identifies BKVN with Graft Injury in BK Viruria Kidney Transplant Recipients

Huang G, Chen X, Yang S, Chen W, Chen P, Hou X, Jiang T, Liu H, Li X, Wang C.[abstract]. Am J Transplant. 2019; 19 (suppl 3).

18) Donor-derived Cell-free Dna In Donor Specific Antibody Positive Kidney Transplant Recipients

Cheng D, Li X, Jiang T, Liu H, Zhou Y, Shi H. [abstract]. Am J Transplant. 2019; 19 (suppl 3).

19) Periphery Blood ddcfDNA Can Significantly Differentiate Acute Humoral Rejection from Banff’s Type I Acute Rejection in Kidney Transplantation

Wang R, Jiang T, Shen J, Ge J, Lei W, Yang X, Deng H, Kong W, Zhou J.[abstract]. Am J Transplant. 2019; 19 (suppl 3).

20) 供体来源游离DNA在移植肾损伤中的研究进展

蒋廷亚周阳程东瑞，《中华器官移植杂志》2019年9月第40卷第9期

21) Dynamics of early post-operative plasma ddcfDNA levels in kidney transplantation: a single-center pilot study

Shen J, Zhou Y, Chen Y, Li X, Lei W, Ge J, Peng W, Wu J, Liu G, Yang G, Shi H, Chen J, Jiang T, Wang R. Transpl Int. 2019 Feb;32(2):184-192.

22) A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant

Zhou Y, Yang G, Liu H, Chen Y, Li X, Ge J, Wang X, Niu H, Dong W, Jiang T, Shi H, Peng L, Liu L.Transplant Proc. 2019 Jul-Aug;51(6):1699-1705.

23) 器官移植术后病原体感染检测研究进展

王啸晨葛军陈雅文蒋廷亚黎小锋杨功达周阳王仁定，《器官移植》2018,9(06):474-477.

24) 游离DNA在器官移植急性排斥反应检测中的应用

陈雅文蒋廷亚杨功达周阳唐笑天刘磊，《中华器官移植杂志》 2018,39(1):58-61.

合作国际会议口头报告

(ATC/ESOT/TTS)

1) Simultaneously detection of ddcfDNA in plasma and urine assist to determine the type of rejection in renal transplant patients

[abstract]. TTS 2020: Oral Presentation 310.2. (https://virtual.tts.org/virtual/lecture/285).

2) Urine Donor-derived Cell-free is Valuable for Predicting BK Polyomavirus-associated Nephropathy in Kidney Transplant Recipients

[abstract]. Am J Transplant. 2021; 21 (suppl 3). (https://atcmeetingabstracts.com/abstract/urine-donor-derived-cell-free-is-valuable-for-predicting-bk-polyomavirus-associated-nephropathy-in-kidney-transplant-recipients/).

3) Donor derived cell-free DNA in donor specific antibody positive kidney transplant recipient

[abstract]. ESOT 2019: Oral Presentation; （https://onlinelibrary.wiley.com/doi/epdf/10.1111/tri.13507 ）

4) Detecting donor derived cell free DNA levels to identify BKVAN and BKV infection combined TCMR

[abstract]. ESOT 2019: Oral Presentation; 4395346

5) Simultaneous quantification of ddcfDNA and noninvasive genotyping of donor’s HLA in renal transplant patients by next-generation sequencing

[abstract]. ESOT 2019: Oral Presentation; 4395393.

6) Detecting donor derived cell-free DNA in urine identify BKVN with graft injury in BK viruria kidney transplant recipients

ESOT 2019: Oral Presentation; 4396189